Literature DB >> 7494044

Evaluation of BACTEC 9240 blood culture system by using high-volume aerobic resin media.

L D Schwabe1, R B Thomson, K K Flint, F P Koontz.   

Abstract

The BACTEC 9240 blood culture system (Becton Dickinson Diagnostic Instrument Systems, Sparks, Md.) is one of three automated, continuous-monitoring systems that is widely used in clinical laboratories. The BACTEC 9240 was compared with the BACTEC NR 660 for the detection of organisms and bacteremic episodes; time to detection of positive cultures; number of false-positive and false-negative cultures; and time needed to load, process, and perform quality control functions by using high-volume aerobic media. Blood specimens (5,282) were inoculated in equal volumes (5 to 10 ml per bottle) into BACTEC Plus Aerobic/F (9240 system) and BACTEC Plus NR26 (660 system) bottles. Clinically significant isolates were detected in 6.6% of cultures, representing 348 microorganisms and 216 bacteremic episodes. Two hundred forty-eight microorganisms were detected by both systems, 48 by the 9240 only and 52 by the 660 only (P = not significant). Of the bacteremic episodes, 158 were detected by both systems, 27 by the 9240 only and 31 by the 660 only (P = not significant). Analysis of data by month revealed equivalent recovery rates for both systems, with the exception of a 30-day period at one study site during which the 660 system detected significantly more microorganisms. Following a proprietary hardware design retrofit of the 9240 instrument, detection rates were again equivalent for the remaining three months at this study site. Positive cultures detected by both systems were detected an average of 4.3 h faster by the 9240 system (21 versus 25.3 h). The numbers of false-positive cultures for the 9240 and 660 systems were 40 (1.0%) and 9 ( < 1.0%), respectively. The numbers of false-negative cultures were five for the 9240 system and three for the 660 system. The 9240 system required 23 s less technologist time per bottle to operate during the 5-day protocol. In conclusion, the BACTEC 9240 used with high-volume Aerobic/F medium is equivalent to the BACTEC 660 used with high volume NR26 medium for the detection of microorganisms and bacteremic episodes. In addition, the 9240 system detects positive cultures more rapidly than the 660 system but requires further evaluation to ensure reliability of instrument components.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494044      PMCID: PMC228434          DOI: 10.1128/jcm.33.9.2451-2453.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  Multicenter comparison of MicroScan and BACTEC blood culture systems.

Authors:  B Wasilauskas; R Gay; P Zwadyk; M Pfaller; F Koontz
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

2.  Multicenter clinical evaluation of a continuous monitoring blood culture system using fluorescent-sensor technology (BACTEC 9240).

Authors:  F S Nolte; J M Williams; R C Jerris; J A Morello; C D Leitch; S Matushek; L D Schwabe; F Dorigan; F E Kocka
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

3.  Detection of bacteremia by Difco ESP blood culture system.

Authors:  J A Morello; C Leitch; S Nitz; J W Dyke; M Andruszewski; G Maier; W Landau; M A Beard
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

4.  Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems.

Authors:  M L Wilson; M P Weinstein; L G Reimer; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

5.  Comparison of Difco ESP and Organon Teknika BacT/Alert continuous-monitoring blood culture systems.

Authors:  P Zwadyk; C L Pierson; C Young
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

  5 in total
  7 in total

1.  Controlled clinical comparison of BACTEC plus anaerobic/F to standard anaerobic/F as the anaerobic companion bottle to plus aerobic/F medium for culturing blood from adults.

Authors:  M L Wilson; S Mirrett; F T Meredith; M P Weinstein; V Scotto; L B Reller
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Update on detection of bacteremia and fungemia.

Authors:  L G Reimer; M L Wilson; M P Weinstein
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  Using the polymerase chain reaction coupled with denaturing gradient gel electrophoresis to investigate the association between bacterial translocation and systemic inflammatory response syndrome in predicted acute severe pancreatitis.

Authors:  Callum B Pearce; Vitaly Zinkevich; Iwona Beech; Viera Funjika; Ana Garcia Ruiz; Afraa Aladawi; Hamish D Duncan
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

4.  Use of simulated blood cultures to compare a specific fungal medium with a standard microorganism medium for yeast detection.

Authors:  H Fricker-Hidalgo; F Chazot; B Lebeau; H Pelloux; P Ambroise-Thomas; R Grillot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

5.  Multicenter clinical comparison of resin-containing bottles with standard aerobic and anaerobic bottles for culture of microorganisms from blood.

Authors:  H Lelièvre; M Gimenez; F Vandenesch; A Reinhardt; D Lenhardt; H M Just; M Pau; V Ausina; J Etienne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

6.  Four-day incubation period for blood culture bottles processed with the Difco ESP blood culture system.

Authors:  G V Doern; A B Brueggemann; W M Dunne; S G Jenkins; D C Halstead; J C McLaughlin
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

7.  Comparison of the BacT/Alert FAN aerobic and the Difco ESP 80A aerobic bottles for pediatric blood cultures.

Authors:  P L Welby-Sellenriek; D S Keller; R J Ferrett; G A Storch
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.